Abstract
Ovarian stimulation is an important step in in vitro fertilization (IVF) therapy which has had a profound impact upon the success or failure of the whole procedure. It is now recognised that no single ovarian stimulation agent or dosage is optimal for all patients and that stimulation should be tailored and adjusted to best suit the patient’s own hormonal status. However, as with every stimulation protocol, 20% to 40% of the patients are cancelled before ovum pick-up mainly due to premature Luteinizing Hormone (LH) surge.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benadiva, C., Ben-Rafael, Z., Strauss, J.F., Mastroianni, L., and Flickinger G.L., 1988, Ovarian response of individuals to different dose of human menopausal gonadotropin, Fertil. Steril., 49:997.
Ben-Rafael, Z., Dor, J., Mashiach, S., Blankstein, J., Lunenfeld B., and Serr D.M., 1983, Abortion rate in pregnancies following ovulation induced by human menopausal gonadotropin/ human chorionic gonadotropin, Fertil Steril 39: 157.
Ben-Rafael, Z., Mastroianni, L., Strauss, J.F., and Flickinger G.L., 1986, Differences in ovarian stimulation in human menopausal gonadotropin treated women may be related to follicle stmulating hormone accumulation., Fertil Steril. 46: 486.
Ben-Rafael, Z., Mastroianni, L., Meloni, F., Lee M.S., and Flickinger G.L., 1986, Total estradiol, free estradiol, sex hormone-binding globulin, and the fraction of estradiol bound to sex hormone binding globulin in human follicular fluid, J. Clin. Endocrinol. Metab., 63: 1106.
Bider, D., Kokia, E., Lipitz, S., Blankstein, J., Mashiach, S, and Ben-Rafael, Z., Failure to improve ovarian response by combined GnRH agonist and gonadotropin therapy. (Submitted).
Defazio J., Meldrum, D.R., Lu, J.K.H., Vale W.W., Rivier J.E., Judd, H.L., and Chang R.J., 1985, Acute ovarian response to long acting agonist of gonadotropin releasing hormone in ovulatory women and women with polycystic ovarian disease, Fertil. Steril., 44:453.
Fleming, R., Haxton, M.J., Hamileton, M.P.R., McCune, G.S. Black, W.B., Macnaughton, M.C., and Coutts, J.R.T., 1985, Successful treatment of infertile women with oligomenorrhea using a combination of LHRH agonist and exogenous gonadotropins, Br. J. Obstet. Gynecol 2: 368.
Fleming, R., and Coutts, J.R.T.,1986, Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropins suppression, Fertil. Steril., 45: 226.
Kenigsberg D., Littman, B.A., and Hodgen G.D., 1986, Induction of ovulation in primate models. Endocrine reviews, 7: 34.
Lemay, A., Sandow, J., Quisnel, G., Bergeron, J., and Merat, P., 1988 Escape from down regulation of pituitary ovarian axis following decreased infusion of luteinizing hormone releasing hormone agonist, Fertil. Steril., 49: 802.
Mashiach, S., Dor, J., Goldenberg, M., Shalev, J., Blankstein, J., Rudak, E., Shoam, Z., Finelt, Z., Nebel, L., Goldman, B., and Ben-Rafael, Z., 1988, Protocols for induction of ovulation: The concept of programmed cycles, in: In vitro fertilization and other assisted reproduction, H.W. Jones, Jr. and C. Schrader., Eds., Annals. of N.Y. Acad. Sci., 541: 37.
Popkin, R., Bramley, T.A., Currie, A., Shaw, R.W., Baird, D.T., Fraser, H.M. 1983, Specific binding of luitenising hormone releasing hormone to human luteal tissue. Biochem. Biophys. Res. Commun., 114:750.
Radwanska, E., Rawlins, R.G., Turmmon, I., Maclin, V., Binor, Z., Damowski, W.P., 1988, Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment, Fertil. Steril. A 9: 356.
Sandow, J., 1983, Clinical applications of LHRH and its analogues, Clin. Endocrinol., 18: 571.
Sheehan, K.L, Casper, R.F, Yen, S.S.C., 1983, Induction of luteolysis by luteinizing hormone releasing factor (LRF) agonist: Sensitivity, reproducibility, and reversibility, Fertil. Steril., 37:209.
Smith, E.M., Anthony, F.W., Gadd, S.C, Mosson., G.M., 1989, Trial of support treatment with human menopausal gonadotropin in the luteal phase after treatment with buserelin and human menopausal gonadotropin in women taking part in an in vitro fertilisation programme, BMJ., 298:1483.
Stucky, B.G.A., Klogh E.G., Pullan P.T., Beilby J.A., Thompson, R.J., and Evans O.V., 1987, Continous gonadotropin-releasing hormone for ovulation induction in polycystic ovarian disease, Fertil. Steril., 48:1055.
Testart, J., Forman, R., Belaish-Alart, J.C., Volante, M., Hazut, A., Strub, N., and Frydman, R., 1989, Embryo quality and uterine receptivity in in vitro fertilization cycles with or without agonists of gonadotropin releasing hormone, Human. Reprod., 4:198.
Torode, H.W., Porter, P.N., Vaughan, J.I., Saunders D.M., 1987, Luteal phase support after in vitro fertilisation: A trial and rationale for selective use, Clinc. Reprod. Fertil., 5:255.
Wildt, L., Diedrich, K., Van der Ven, H., Hasani, S. Al., Huber, H., and Klasen, R., 1986, Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotropin, Human. Reprod 1:15.
Zeleznik, A.J., and Kubik C.J., 1986, Ovarian response in Macaques to pulsatile infusion of follicle-stimulating hormone (FSH) and luteinizing hormone: Increased sensitivity of maturing follicle to FSH, Endocrinology, 119:2025.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Ben-Rafael, Z. et al. (1990). Limitations in the Use of Combined Gonadotropin Releasing Hormone Analog and Human Menopausal Gonadotropin for In Vitro Fertilization. In: Mashiach, S., Ben-Rafael, Z., Laufer, N., Schenker, J.G. (eds) Advances in Assisted Reproductive Technologies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0645-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0645-0_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7907-5
Online ISBN: 978-1-4613-0645-0
eBook Packages: Springer Book Archive